These emerging therapies , Tirzepatide , represent a groundbreaking advancement in managing type 2 diabetes and potentially related ailments . These drugs are classified as GLP-1 pathway activators , meaning these substances to emulate the natural GLP-1 substance , enhancing insulin production an